Medpace Holdings Inc MEDP

$610.54 -23.44 (-3.70%)

Valuation

Market cap
17,733,688,000
Revenue TTM
$2,530,230,000
Net income TTM
$451,120,000
P/E (trailing)
35.86
P/E (forward)
35.82
Profit margin
17.83%
Debt to equity
0.00

Trading

Volume
236,700
Avg volume
275,434
Day's range
$606.73 – $633.87
Shares out
27,972,000
Stochastic %K
6%
Beta
1.12
Analysts
Hold
Price target
$675.92

Price

Company profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries;...

Show more

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
513 579 9911
Website
https://www.medpace.com
Address
5375 Medpace Way, Cincinnati, United States

Latest news

No headlines yet.